Biocept logo

Biocept Funding & Investors

Biocept, Inc. is a commercial-stage cancer diagnostics company. The Company focuses on developing and commercialization proprietary circulating tumor cell and circulating tumor DNA tests. Biocept serves patients and customers in the State of California.

biocept.com

Total Amount Raised: $48,200,000

Biocept Funding Rounds

  • Post Ipo Equity

    $5,000,000

  • Post Ipo Equity

    $14,800,000

  • Post Ipo Equity

    $9,300,000

    Post Ipo Equity Investors

    Roth Capital Partners
    Chardan Capital
  • Debt Financing

    $1,200,000

  • Series B

    $2,299,999

  • Series A

    $3,600,000

  • Series Unknown

    $10,000,000

    Series Unknown Investors

    Needham Capital Partners
  • Series Unknown

    $2,000,000

  • IPO

    Unknown

Funding info provided by Diffbot.